| Expression pattern: |
DN |
| Associated gene: |
SNCA, APOE, PSEN1 |
| Associated microRNA: |
miR-455-3p |
| Biological function: |
associated with AD progression; depletion may release miR-455-3p and enhance its activity |
| Molecular mechanism: |
Predicted miRNA sponging/release mechanism along severity: progressive downregulation releases miR-455-3p, enhancing miR-455-3p activity and downregulating its targets |
| Biological pathway or process: |
ceRNA regulation (inhibits); other pathway/process (other) |
| Detected method: |
S
|
| Validation methods: |
RNA-seq; Bioinformatics Analysis |
| Clinical significance: |
correlates with AD progression/severity (consistent depletion with increased AD severity) |
| Description: |
ASAP1-12100-A5BS shows progressive depletion with increasing AD severity in BM36. It is predicted to bind miR-455-3p, and its downregulation is associated with enhanced miR-455-3p activity and downstream suppression of miR-455-3p target genes, suggesting a role in AD progression. |
| Confidence score: |
0.1768 |